Stable transplantation results of magnetically retracted islets: a novel method

Aims/hypothesisLarge quantities of pure viable donor islets are necessary for clinical transplantation. At present, low yields and low viability of pancreatic islets after transplantation necessitate the use of multiple donors for a single recipient. In this study an improved method for obtaining large quantities of pure viable islets of Langerhans for transplantation was developed in the rat.MethodsIslets of Langerhans were isolated from Albino Oxford rats. The donor pancreata were perfused in situ with iron oxide, which resulted in entrapment of iron particles in the capillaries of the islets. Subsequently, the islets were isolated by magnetic retraction. Islets obtained with this method were compared with islets obtained by density gradient-isolated islets with respect to yields, purity, and insulin production capacity. Islets isolated with the magnetic retraction method were transplanted under the renal capsule of streptozotocin-induced diabetic recipients. Blood-glucose levels in the recipients were monitored for 2 months after transplantation.ResultsThis method yielded more pure and viable islets than the conventional protocol. No contamination of exocrine tissue was observed after isolation. Furthermore, the islets isolated by magnetic retraction stained strongly positive for insulin during the entire observation period in vitro, and produced high amounts of insulin upon a challenge with glucose. The islets that were obtained by this new protocol were suitable for safe and effective transplantation.Conclusions/interpretationWe have shown that both the quantity and quality of islets obtained with this method were sufficient to induce insulin independence in a diabetic recipient using islets from only one donor.

[1]  J. Ringers,et al.  Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure , 1999, The Lancet.

[2]  R. Jindal The use of zinc binding dyes and fluorescence-activated islet sorters. , 1995, Pancreas.

[3]  S. Frisch,et al.  Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.

[4]  P. de Vos,et al.  Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? , 1999, Diabetes.

[5]  L. Rosenberg,et al.  Maintenance of beta-cell function and survival following islet isolation requires re-establishment of the islet-matrix relationship. , 1999, The Journal of endocrinology.

[6]  W. Rau,et al.  Improved survival of intraportal pancreatic islet cell allografts in patients with type-1 diabetes mellitus by refined peritransplant management , 1999, Journal of Molecular Medicine.

[7]  D. Dunn,et al.  Lessons Learned From More Than 1,000 Pancreas Transplants at a Single Institution , 2001, Annals of surgery.

[8]  G. Korbutt,et al.  RAT PANCREAS PREPARATION FOR COLD STORAGE AND SUBSEQUENT ISLET CELL ISOLATION , 1993, Transplantation.

[9]  P. Soon-Shiong,et al.  Rapid purification of islets using magnetic microspheres coated with anti-acinar cell monoclonal antibodies. , 1990, Transplantation.

[10]  M. Mannik,et al.  A method for isolation of mouse glomeruli for quantitation of immune deposits. , 1988, Kidney international.

[11]  E. Ryan,et al.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. , 2000, The New England journal of medicine.

[12]  A. Monaco,et al.  IMMUNOLOGICAL CHARACTERISTICS OF PURIFIED PANCREATIC ISLET GRAFTS , 1986, Transplantation.

[13]  H. Hammes,et al.  Angiogenic capacity of endothelial cells in islets of Langerhans , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  Å. Lernmark,et al.  Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. , 1999, Diabetes.

[15]  L. Rosenberg,et al.  Factors mediating the transdifferentiation of islets of Langerhans to duct epithelial-like structures. , 2001, The Journal of endocrinology.

[16]  P. Morel,et al.  Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantations. , 2000, Transplantation.

[17]  S. Swift,et al.  Human islet cell transplantation – future prospects , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[18]  Emile de Heer,et al.  Optimal method for RNA extraction from mouse glomeruli. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  M. Menger,et al.  Exocrine contamination of isolated islets of Langerhans deteriorates the process of revascularization after free transplantation. , 2000, Transplantation.

[20]  P. Lacy,et al.  Automated Islet Isolation From Human Pancreas , 1989, Diabetes.

[21]  J. R. Henderson,et al.  A morphometric study of the endocrine and exocrine capillaries of the pancreas. , 1985, Quarterly journal of experimental physiology.

[22]  R. Stratta,et al.  Pancreas and islet transplantation for patients with diabetes. , 2000, Diabetes care.

[23]  W. Göhde,et al.  Separation of Pancreatic Islets by Fluorescence-Activated Sorting , 1989, Diabetes.

[24]  J. Davies,et al.  A comparison of the use of two immunomagnetic microspheres for secondary purification of pancreatic islets. , 1996, Transplantation.

[25]  S. Swift,et al.  Isolation, culture and functional evaluation of islets of Langerhans. , 1998, Diabetes & metabolism.

[26]  C. Manske Risks and benefits of kidney and pancreas transplantation for diabetic patients. , 1999, Diabetes care.

[27]  F. Ris,et al.  Factors affecting human islet of Langerhans isolation yields. , 2002, Transplantation proceedings.